Researchers from Dr. Boris Striepen’s lab tracked Cryptosporidium in real time, creating a new paradigm for how the widespread parasite reproduces in a host.
Researchers in the School of Veterinary Medicine and colleagues have developed a gene therapy that restores dim-light vision in dogs with a congenital form of night blindness, offering hope for treating a similar condition in people.
Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges.
Thomas D. Parsons, Christopher J. Lengner and Amy L. Johnson have been recognized for scholarly achievements.
The Royal Veterinary College – together with Penn Vet and MARS EQUESTRIAN™ – has launched a new, international scholarship program aimed at advancing the health and welfare of horses.
The Pennsylvania Horse Breeders Association announced a $150,000 donation to the Equine Pharmacology Laboratory at Penn Vet's New Bolton Center that will support continued revolutionary research in equine biomarkers.
A report led by Penn Vet's Dr. Elizabeth Lennon and colleagues has confirmed what is believed to be the first published account of the delta variant of SARS-CoV-2 in a house cat.
In humans the pandemic is showing signs of ebbing. In white-tailed deer and other wildlife, however, infections appear widespread.
Penn Vet's Institute for Infectious and Zoonotic Diseases announced inaugural Martin and Pamela Winter Infectious Disease Fellowships of $35,000 each to two, early-career biomedical scientists
New findings from the lab of Dr. P. Jeremy Wang shed light on the cell division process that creates eggs and sperm, recurrent pregnancy loss, and the mechanism by which sperm move.
Dr. William A. Beltran and Dr. David M. Gamm have been awarded CAD$725,000 from Fighting Blindness Canada’s Restore Vision 20/20 program to continue their ground-breaking research into cell replacement therapy for retinitis pigmentosa, an inherited retinal disease.
A team led by the School of Veterinary Medicine’s M. Andrés Blanco has uncovered a new target for treating certain blood cancers that works by removing an obstacle to their maturation.
Horse owners usually dread hearing the diagnosis of “Laminitis.” The disease plagues horses of many backgrounds, ages and disciplines. Using genetics, UF/IFAS and University of Pennsylvania scientists have made a breakthrough in the disease thanks to funding from The Foundation for the Horse.
The Human Animal Bond Research Institute announces it has awarded a new research grant to Penn Vet to investigate whether pets are a source of microbiota that can help restore deficiencies in their owner’s gut microbiome.
Penn Vet’s unique new Institute for Infectious Zoonotic Diseases
Dr. Michael Povelones considers how the chain of disease transmission could be halted before a pathogen ever leaves the mosquito vector.
Signaling the world’s vulnerability to disease, Penn Vet is launching the Institute for Infectious and Zoonotic Diseases to confront emerging and re-emerging zoonotic and vector-borne diseases, with a goal of fostering innovations in disease surveillance, treatment, and vaccine development.
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders, and perhaps other genetic conditions.
Penn Vet's Working Dog Center has launched a new video, “Two Decades Since 9/11: A Tribute.”
Igor Brodsky, AB, PhD, has been appointed Chair of the Department of Pathobiology at Penn Vet effective October 1, 2021.